Activation of p38MAPK mediates the angiostatic effect of the chemokine receptor CXCR3-B

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 9, 2008, Pages 1764-1774

  Petrai, Ilaria ^a   Rombouts, Krista ^a   Lasagni, Laura ^a   Annunziato, Francesco ^a   Cosmi, Lorenzo ^a   Romanelli, Roberto G ^a   Sagrinati, Costanza ^a   Mazzinghi, Benedetta ^a   Pinzani, Massimo ^a   Romagnani, Sergio ^a   Romagnani, Paola ^a   Marra, Fabio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiogenesis; Chemokines; Endothelial cells; Mitogen activated protein kinase; Signal transduction

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR3A; CHEMOKINE RECEPTOR CXCR3B; CXCL4 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ISOENZYME; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SB 302580; STRESS ACTIVATED PROTEIN KINASE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANGIOSTATIC PROTEINS; CELL LINE; CHEMOKINE CXCL10; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET FACTOR 4; PROTEIN ISOFORMS; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION;

EID: 44649146341     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.01.008     Document Type: Article

References (50)

1. Bonacchi A., Romagnani P., Romanelli R.G., Efsen E., Annunziato F., Lasagni L., et al. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem. 276 13 (2001) 9945-9954
2. Brault S., Gobeil Jr. F., Fortier A., Honore J.C., Joyal J.S., Sapieha P.S., et al. Lysophosphatidic acid induces endothelial cell death by modulating the redox environment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 3 (2007) R1174-R1183
3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 7070 (2005) 932-936
4. Chai W., and Liu Z. p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kappaB degradation in human coronary artery endothelial cells. Endocrinology 148 4 (2007) 1622-1628
5. Datta D., Flaxenburg J.A., Laxmanan S., Geehan C., Grimm M., Waaga-Gasser A.M., et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res. 66 19 (2006) 9509-9518
6. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267 5198 (1995) 682-685
7. Ferrari G., Pintucci G., Seghezzi G., Hyman K., Galloway A.C., and Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 103 46 (2006) 17260-17265
8. Giuliani N., Bonomini S., Romagnani P., Lazzaretti M., Morandi F., Colla S., et al. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. Haematologica 91 11 (2006) 1489-1497
9. Huo Y., Schober A., Forlow S.B., Smith D.F., Hyman M.C., Jung S., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9 1 (2003) 61-67
10. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 9 6 (2003) 685-693
11. Kasper B., Brandt E., Bulfone-Paus S., and Petersen F. Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103 5 (2004) 1602-1610
12. Kolber D.L., Knisely T.L., and Maione T.E. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J. Natl. Cancer Inst. 87 4 (1995) 304-309
13. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197 11 (2003) 1537-1549
14. Lasagni L., Grepin R., Mazzinghi B., Lazzeri E., Meini C., Sagrinati C., et al. PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion. Blood 109 10 (2007) 4127-4134
15. Lazzeri E., and Romagnani P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5 1 (2005) 109-118
16. Lee J.C., Kassis S., Kumar S., Badger A., and Adams J.L. p38 mitogen-activated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol. Ther. 82 2/3 (1999) 389-397
17. Li J., Deane J.A., Campanale N.V., Bertram J.F., and Ricardo S.D. Blockade of p38 mitogen-activated protein kinase and TGF-beta1/Smad signaling pathways rescues bone marrow-derived peritubular capillary endothelial cells in adriamycin-induced nephrosis. J. Am. Soc. Nephrol. 17 10 (2006) 2799-2811
18. Luster A.D., Greenberg S.M., and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182 1 (1995) 219-231
19. Luster A.D., and Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178 3 (1993) 1057-1065
20. Maione T.E., Gray G.S., Hunt A.J., and Sharpe R.J. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51 8 (1991) 2077-2083
21. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247 4938 (1990) 77-79
22. Marra F., Delogu W., Petrai I., Pastacaldi S., Bonacchi A., Efsen E., et al. Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287 1 (2004) G18-G26
23. Monaghan T.K., Mackenzie C.J., Plevin R., and Lutz E.M. PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J. Neurochem. (2007)
24. Ohta T., Eguchi R., Suzuki A., Miyakaze S., Ayuzawa R., and Kaji K. Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells. J. Cell. Physiol. 211 3 (2007) 673-681
25. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., et al. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102 11 (1998) 1942-1950
26. Pervushina O., Scheuerer B., Reiling N., Behnke L., Schroder J.M., Kasper B., et al. Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J. Immunol. 173 3 (2004) 2060-2067
27. Petersen F., Bock L., Flad H.D., and Brandt E. A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J. Immunol. 161 8 (1998) 4347-4355
28. Petersen F., Bock L., Flad H.D., and Brandt E. Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8. Blood 94 12 (1999) 4020-4028
29. Petersen F., Brandt E., Lindahl U., and Spillmann D. Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. J. Biol. Chem. 274 18 (1999) 12376-12382
30. Rollins B.J. Inflammatory chemokines in cancer growth and progression. Eur. J. Cancer 42 6 (2006) 760-767
31. Romagnani P., Annunziato F., Lasagni L., Lazzeri E., Beltrame C., Francalanci M., et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107 1 (2001) 53-63
32. Romagnani P., Lasagni L., Annunziato F., Serio M., and Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 25 4 (2004) 201-209
33. Romagnani P., Maggi L., Mazzinghi B., Cosmi L., Lasagni L., Liotta F., et al. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J. Allergy Clin. Immunol. 116 6 (2005) 1372-1379
34. Rotondi M., Falorni A., De Bellis A., Laureti S., Ferruzzi P., Romagnani P., et al. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J. Clin. Endocrinol. Metab. 90 4 (2005) 2357-2363
35. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78 6 (1994) 1027-1037
36. Sachais B.S., Higazi A.A., Cines D.B., Poncz M., and Kowalska M.A. Interactions of platelet factor 4 with the vessel wall. Semin. Thromb. Hemost. 30 3 (2004) 351-358
37. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr. Opin. Pharmacol. 4 4 (2004) 372-377
38. Salcedo R., Resau J.H., Halverson D., Hudson E.A., Dambach M., Powell D., et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14 13 (2000) 2055-2064
39. Schober A., Manka D., von Hundelshausen P., Huo Y., Hanrath P., Sarembock I.J., et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106 12 (2002) 1523-1529
40. Sharpe R.J., Byers H.R., Scott C.F., Bauer S.I., and Maione T.E. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J. Natl. Cancer Inst. 82 10 (1990) 848-853
41. Strieter R.M., Burdick M.D., Gomperts B.N., Belperio J.A., and Keane M.P. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 16 6 (2005) 593-609
42. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270 45 (1995) 27348-27357
43. Struyf S., Burdick M.D., Peeters E., Van den Broeck K., Dillen C., Proost P., et al. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. Cancer Res. 67 12 (2007) 5940-5948
44. Struyf S., Burdick M.D., Proost P., Van Damme J., and Strieter R.M. Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. Circ. Res. 95 9 (2004) 855-857
45. Sulpice E., Contreres J.O., Lacour J., Bryckaert M., and Tobelem G. Platelet factor 4 disrupts the intracellular signalling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms. Eur. J. Biochem. 271 16 (2004) 3310-3318
46. Tanaka T., Manome Y., Wen P., Kufe D.W., and Fine H.A. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat. Med. 3 4 (1997) 437-442
47. Taub D.D., Lloyd A.R., Conlon K., Wang J.M., Ortaldo J.R., Harada A., et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177 6 (1993) 1809-1814
48. von Hundelshausen P., and Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100 1 (2007) 27-40
49. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 1 (2005) 11-18
50. Zipin-Roitman A., Meshel T., Sagi-Assif O., Shalmon B., Avivi C., Pfeffer R.M., et al. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 67 7 (2007) 3396-3405